Physicians' Academy for Cardiovascular Education

Real-world evidence with PCSK9i mAb; implications and lessons for current clinical use

Listen to the podcast
10' education - Oct. 12, 2022 - Raul Santos, MD, PhD (São Paulo, Brazil) & Prof. Maciej Banach, MD, PhD (Lodz, Poland)

Video navigation menu

  • Safety of very low cholesterol levels 02:57
  • Safety of PCSK9 mAbs 06:40
  • Importance of patient education to improve adherence 08:11


Show transcript


Raul Santos, MD, PhD is director of the Lipid Clinic at the Heart Institute (InCor) and associate professor of the University of São Paulo (USP) Medical School, Brazil. Maciej Banach, MD, PhD is full professor of Preventative Cardiology, Epidemiology, and Lipidology at The Medical University of Lodz, Poland.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Sanofi.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: